Adverse Side Effects of Crizotinib in the Treatment of Anaplastic Lymphoma Kinase-Mutated Non-small Cell Lung Cancer: A Systematic Review

Lung cancer is the leading cause of cancer deaths worldwide, with the majority consisting of non-small cell lung cancer (NSCLC). Genetic mutations present an opportunity for targeted therapy, in addition to current mainstay treatments such as chemotherapy and radiotherapy. Overall, 5% of NSCLCs have...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Sherie, Shahi, Srushti R, Ali, Zahra, Abaza, Abdelrahman, Jamil, Aneeque, Gutlapalli, Sai Dheeraj, Ali, Marya, Oble, Mrinal J P, Sonia, Shamsun Nahar, Hamid, Pousette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585412/
https://www.ncbi.nlm.nih.gov/pubmed/37868485
http://dx.doi.org/10.7759/cureus.45517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585412/
https://www.ncbi.nlm.nih.gov/pubmed/37868485
http://dx.doi.org/10.7759/cureus.45517

Ejemplares similares